Results 161 to 170 of about 5,853,531 (371)
Molecular Evaluation of Vitamin D3 Receptor Agonists Designed for Topical Treatment of Skin Diseases11The authors declared not to have conflict of interest [PDF]
, 2001 Yvonne Bury +5 more
openalex +1 more source
Financial Deregulation and Crisis:An ‘Agency-conflict’ Case of Japan [PDF]
The main focus of this paper is on the ‘agency-conflict’ during financial deregulations in the 1980s as the potential causality of Japanese banking crisis in the 1990s.
Hossain, Monzur
core +1 more source
Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma
Molecular Oncology, EarlyView.GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski +19 more
wiley +1 more source
How Should Journals Handle the Conflict of Interest of Their Editors?: Who Watches the "Watchers"?
Journal of the American Medical Association (JAMA), 2017 Julie Gottlieb, N. Bressler
semanticscholar +1 more source
Bankers on Boards: Monitoring, Conflicts of Interest, and Lender Liability
, 1999 Randall S. Kroszner, Philip E. Strahan
openalex +1 more source
Conflicts of interest between the prescriber, the regulator and the profit maker [PDF]
, 2001 William F. Holmes
openalex +1 more source
Molecular Oncology, EarlyView.This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau +9 more
wiley +1 more source